Navigation Links
Aloka to Unveil New 'ProSound' Diagnostic Ultrasound System at the 17th World Congress on Ultrasound in Obstetrics and Gynecology, 7th to 11th of October 2007 in Florence, Italy
Date:10/3/2007

TOKYO, Oct. 3 /PRNewswire/ -- ALOKA is announcing today 3 new models of ProSound Systems which will be unveiled at the 17th World Congress on Ultrasound in Obstetrics and Gynecology, 7th to 11th of October 2007 in Florence, Italy. The ProSound alpha 7 is a powerful, friendly and compact premium ultrasound system, the ProSound 3500SX represents a significant upgrade to Aloka's best selling color system worldwide and the ProSound 6 is a new premium gray scale ultrasound system.

"Our challenge is to build versatile and high performance ultrasound systems in very compact design centered around user and patient needs. Environmental care is also a key factor to design, since we commit to human healthcare business" said Dr. Yoshihiro Yoshikawa, President of ALOKA.

The ProSound alpha 7 inherits the technologies from the company's flagship model ProSound alpha 10. Some of the key features include the Directional eFLOW(TM) which visualizes blood flow dynamics from low to high velocity flow without overlapping and with a high degree of accuracy. Also included are basic imaging performance enhancements with Broadband Harmonics(TM), ExPHD(TM) - Extended Pure Harmonic Detection, and high temporal resolution to aid in the diagnoses of fetal heart conditions.

"The eFLOW technology that has been carried over from the premium system of Aloka brings this valuable application to a wider scale of users. The excellent spatial resolution of this Doppler imaging modality was convincing on the alfa7 also for the examination of the fetal heart. Both patients and specialist alike are likely to benefit from this advanced technology." said Dr. Bence Csapo, Department of Obstetrics and feto-maternal Medicine, University of Vienna, Austria.

Real-time 3D(4D) display and AVM(TM)-Automated Volume Measurement function are also available. At AVM(TM), the operator simply specifies the ROI and the system automatically detects the edge and calculates hyper-echoic or hypo- echoic part automatically at high degrees of accuracy.

The ProSound alpha 7 employs a full ergonomic design with height adjustable console and monitor. The compact ProSound alpha 7 is the smallest dimension in its class. Both light in weight and compact in size the ProSound alpha 7 are truly mobile. The system consumes 40% less electric power than previous model, designed for material efficiency, with reduction in the use of chemical material with recycling in mind.

The ProSound 3500SX offers significant enhancements to the ProSound 3500. Over 10,000 of the previous ProSound 3500 system have been installed world wide and the company introduced ProSound 3500SX with ergonomic enhancements and with a flat panel display (FPD). Real-time 3D(4D) is available as an option and the company is preparing several major updates in the coming months.

The ProSound 6 is a premium gray scale ultrasound system. In a very compact body, ProSound technologies such as ExPHD(TM), MFI(TM)-Multi Frequency Imaging, edge enhancement function are included as standard features. A variety of transducers are available to cover a wide range of clinical applications and the system offers high resolution imaging on each transducer.

Corporate Profile

Aloka Co., Ltd. is a pioneer in the development of diagnostic ultrasound systems. Our diagnostic ultrasound systems are used worldwide.

We commercialized electronic convex sector scanner and Color Doppler systems that displays blood flow images, which are indispensable for today's ultrasound examination, first in the world. The cumulative production of Aloka's diagnostic ultrasound systems has exceeded 200,000 units as of December, 2006 as a world first as a single brand.

Aloka's corporate philosophy is encapsulated in the words, "The preciousness of life" and "Save as many lives as possible." Under this philosophy, Aloka's creativity and technological innovation will continually evolve to serve both patients and health-care professionals. Aloka is committed to the creation of a society based on a friendly relationship between medicine and people.

http://www.aloka.com

Contact:

Hiroyuki SHIKATA

Marketing Department

ALOKA Co., Ltd.

Phone: +81-422-45-5125

Fax: +81-422-45-7751

E-mail: shik1544@am.aloka.co.jp

URL: http://www.aloka.com


'/>"/>
SOURCE Aloka Co., Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Ecstasy shrinks brain!!-researchers unveil the secrets of MDMA.
2. Canine Painkiller unveiled by Novartis
3. Skin cancers secrets unveiled
4. Pfizer unveils anti-smoking drug
5. WHO and UNAIDS unveil plan to get 3 million AIDS patients on treatment by 2005
6. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
7. Study Unveils New Insight To The Madness Of King George III
8. Bush Unveils Latest Blueprint for Handling Bird Flu Pandemic
9. Rae unveils Health-care Strategy
10. Study Unveils West Nile Virus Immune Evasion, Points to Vaccine Development
11. New Health Insurance Scheme for Diabetics Unveiled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... , media relations, content marketing, social media management, corporate communications, SEO and cause ... the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus ...
(Date:2/23/2017)... Colorado (PRWEB) , ... February 23, 2017 , ... ... Magazine, an exciting, new, interactive publication where generations converge and explore the world ... expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... new partnership with the Rhode Island Consortium for Autism Research and Treatment (RI-CART) ... for children with autism spectrum disorder (ASD) to see films in an environment ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... York (PRWEB) , ... February 22, 2017 , ... ... entrance and lobby of a new healthcare contact center in Georgia, PENETRON Specialty ... One of the nation’s largest healthcare systems recently invested $51 million to purchase ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017  Cogentix Medical, Inc. ... and markets innovative proprietary products for the urology market, ... fiscal year ended December 31, 2016 before the market ... The Company will host a conference call and webcast ... Thursday, March 9, 2017 at 11:00 a.m. Eastern Time ...
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has announced ... 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - ... The research answers the following questions: ... How are they positioned in the Global Menopause market? ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Fibromyalgia Drugs Price ... in the global Fibromyalgia market. The research answers the ... marketed for Fibromyalgia and their clinical attributes? How are they positioned ...
Breaking Medicine Technology: